Co-Diagnostics, Inc.
Ticker: 1692415
Stock Split in 3 days
P/L Snapshot
Q3 FY26 · consolidated
vs Q2 FY26·vs Q3 FY25
Revenue
0.28
+64.7%+86.7%
Expenditure
6.55
+2.8%-8.5%
Net Profit
-6.31
-0.5%-7.1%
OPM %
-100.00%
Shareholding
Pattern breakdown
P/L Trends
(in millions)
RevenueExpenditureNet Profit
Price Chart
Latest News
Corporate Events
Board MeetingCODX
202613Nov
Board Meeting
Special Meeting of Shareholders to elect directors, approve …
SEC Filing ↗ Board MeetingCODX
20263Sep
Board Meeting
Annual Meeting of Stockholders adjourned due to lack of quor…
SEC Filing ↗ Board MeetingCODX
20262Sep
Board Meeting
CFO Transition - Brian Brown departs as CFO; Daniel Bohrer a…
SEC Filing ↗